Management of polycystic ovary syndrome
- PMID: 9437670
Management of polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS), also known as Stein-Leventhal Syndrome, is a condition that afflicts many women during their childbearing years. It is one of the leading causes of female infertility. Symptoms of PCOS are related to androgen excess and are not associated with estrogen deficiency. Classic symptoms include amenorrhea, hirsutism, acne, and obesity. Management of PCOS is directed by the client's concerns regarding symptoms, desire for pregnancy, and degree of morbidity related to androgen excess. First-line management of PCOS includes diet modification, weight loss, and stress management. First-line treatment for androgen excess is estrogen therapy, the combination of estrogen and progesterone being the drugs of choice. Uncomplicated amenorrhea in PCOS is managed with monthly or bimonthly administration of medroxyprogesterone. The antiestrogen clomiphene citrate has been the drug of choice for inducing ovulation. The success of any treatment plan will depend largely on the client's ability to reduce body weight.
Similar articles
-
Polycystic ovary syndrome: aetiology and management.Br J Hosp Med. 1996 Jun 19-Jul 9;56(1):17-20. Br J Hosp Med. 1996. PMID: 8831007 Review.
-
Comprehensive clinical management of polycystic ovary syndrome.Minerva Med. 2007 Jun;98(3):175-89. Minerva Med. 2007. PMID: 17592439 Review.
-
Evaluation and therapy of polycystic ovarian syndrome.Endocrinol Metab Clin North Am. 1988 Dec;17(4):785-813. Endocrinol Metab Clin North Am. 1988. PMID: 3143568 Review.
-
Ovulation induction management of PCOS.Clin Obstet Gynecol. 2007 Mar;50(1):255-67. doi: 10.1097/GRF.0b013e31802f361e. Clin Obstet Gynecol. 2007. PMID: 17304040
-
Polycystic ovary syndrome.Best Pract Res Clin Obstet Gynaecol. 2008 Apr;22(2):261-74. doi: 10.1016/j.bpobgyn.2007.07.009. Epub 2007 Sep 5. Best Pract Res Clin Obstet Gynaecol. 2008. PMID: 17804299 Review.
Cited by
-
Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure.Cells. 2019 Dec 19;9(1):13. doi: 10.3390/cells9010013. Cells. 2019. PMID: 31861598 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical